Advertisement
Advertisement

Archive

2014: 111/5(May) pp. 781-1006

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Topic:

Theme Issue
New oral anticoagulants for stroke prevention in atrial fibrillation


26 articles
1.

Theme Issue Editorial for Theme Issue "Novel oral anticoagulants"

S. Husted (1), R. De Caterina (2), F. Andreotti (3), H. Arnesen (4), F. Bachmann (5), K. Huber (6), J. Jespersen (7), S. D. Kristensen (8), G. Y. H. Lip (9), J. Morais (10), L. H. Rasmussen (11), A. Siegbahn (12), R. F. Storey (13), J. I. Weitz (14), on behalf of the ESC Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease

(1) Medical Department, Hospital Unit West, Denmark; (2) Institute of Cardiology & Center of Excellence on Aging, G. d’Annunzio University, Chieti, Italy; (3) Department of Cardiovascular Science, Catholic University, Rome, Italy; (4) Center for Clinical Heart Research, Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway; (5) University of Lausanne, Switzerland; (6) 3rd Department of Medicine, Wilhelminenspital, Vienna, Austria; (7) Unit for Thrombosis Research, Institut of Public Health, University of Southern Denmark, Denmark; (8) Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark; (9) University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; (10) Cardiology Division, Santo Andre´s Hospital, Leiria, Portugal; (11) Thrombosis Research Centre, Department of Clinical Medicine, Faculty of Medicine, Aalborg University, Denmark and Department of Cardiology, Aalborg University Hospital, Denmark; (12) Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden; (13) Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom; (14) Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Canada McMaster University, Hamilton, Canada

Thromb Haemost 2014 111 5: 781-782

https://doi.org/10.1160/TH14-03-0228

[Summary] [Free PDF] [Export citation]
2.

Theme Issue Article for Theme Issue "Novel oral anticoagulants"

E. M. Hylek (1), D. Ko (1), C. L. Cove (1)

(1) Boston University School of Medicine, Department of Medicine, Boston, Massachusetts, USA

Thromb Haemost 2014 111 5: 783-788

https://doi.org/10.1160/TH13-12-1032

[Summary] [Free PDF] [Export citation]
3.

Theme Issue Article for Theme Issue "New oral anticoagulants"

C.-E. Chiang (1), K.-L. Wang (1), G. Y. H. Lip (2)

(1) General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan; (2) University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK

Thromb Haemost 2014 111 5: 789-797

https://doi.org/10.1160/TH13-11-0948

[Summary] [Free PDF] [Export citation]
4.

Theme Issue Article for Theme Issue "New oral anticoagulants"

N. C. Chan (1, 3), J. S. Paikin (2), J. Hirsh (2, 3), M. N. Lauw (1, 2, 4), J. W. Eikelboom (1, 2, 3), J. S. Ginsberg (2, 3)

(1) Population Health Research Institute, Hamilton, Canada; (2) Department of Medicine, McMaster University, Hamilton, Canada; (3) Thrombosis and Atherosclerosis Research Institute, Hamilton, Canada; (4) Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands

Thromb Haemost 2014 111 5: 798-807

https://doi.org/10.1160/TH13-11-0918

[Summary] [Free PDF] [Export citation]
5.

Theme Issue Article for Theme Issue "New oral anticoagulants"

G. J. Hankey (1, 2)

(1) School of Medicine and Pharmacology, The University of Western Australia, Nedlands, Perth, Australia; (2) Department of Neurology, Sir Charles Gairdner Hospital, Nedlands, Perth, Australia

Thromb Haemost 2014 111 5: 808-816

https://doi.org/10.1160/TH13-09-0741

[Summary] [Free PDF] [Export citation]
6.

F. Violi (1), P. Pignatelli (1)

(1) I Clinica Medica, Department of Internal Medicine and Medical Specialties, Roma, Italy

Thromb Haemost 2014 111 5: 817-823

https://doi.org/10.1160/TH13-10-0818

[Summary] [Free PDF] [Export citation]
7.

M. L. V. Hendrickx (1), M. Zatloukalova (1), G. Hassanzadeh-Ghassabeh (2, 3), S. Muyldermans (2, 4), A. Gils (1), P. J. Declerck (1)

(1) Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium; (2) Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Belgium; (3) Nanobody Service facility (NSF), VIB, Brussels, Belgium; (4) VIB Department of Structural Biology, Brussels, Belgium

Thromb Haemost 2014 111 5: 824-832

https://doi.org/10.1160/TH13-08-0645

[Summary] [PDF] [Pay per view] [Export citation]
8.

J.-Y. Le Heuzey (1), B. Ammentorp (2), H. Darius (3), R. De Caterina (4), R. J. Schilling (5), J. Schmitt (2), J. L. Zamorano (6), P. Kirchhof (7, 8)

(1) Cardiology and Arrhythmology, Georges Pompidou Hospital, René Descartes University, Paris, France; (2) Daiichi Sankyo Europe, Munich, Germany; (3) Department of Cardiology, Vivantes Hospital Neukölln, Berlin, Germany; (4) Institute of Cardiology G. d’Annunzio, University Chieti-Pescara, Italy; (5) Barts and St. Thomas Hospital, London, UK; (6) Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain; (7) University of Birmingham Centre for Cardiovascular Sciences and SWBH NHS Trust, Birmingham, UK; (8) Department of Cardiovascular Medicine, Hospital of the University of Münster, Germany

Thromb Haemost 2014 111 5: 833-841

https://doi.org/10.1160/TH13-12-1007

[Summary] [PDF] [Pay per view] [Export citation]
9.

Online Supplementary Material

C. Duval (1), P. Allan (1, 2), S. D. A. Connell (2), V. C. Ridger (3), H. Philippou (1), R. A. S. Ariëns (1)

(1) Theme Thrombosis, Division of Cardiovascular and Diabetes Research, Leeds Institute of Genetics, Health and Therapeutics and Multidisciplinary Cardiovascular Research Centre, Faculty of Medicine and Health, University of Leeds, UK; (2) Molecular and Nanoscale Physics Group, School of Physics and Astronomy, University of Leeds, UK; (3) Department of Cardiovascular Science, Faculty of Medicine, Dentistry, and Health, University of Sheffield, UK

Thromb Haemost 2014 111 5: 842-850

https://doi.org/10.1160/TH13-10-0855

[Summary] [PDF] [Pay per view] [Export citation]
10.

A. Pavlova (1), D. Delev (2), B. Pezeshkpoor (1), J. Müller (1), J. Oldenburg (1)

(1) Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany; (2) Clinic and Policlinic for Neurosurgery, University Clinic Bonn, Bonn, Germany

Thromb Haemost 2014 111 5: 851-861

https://doi.org/10.1160/TH13-08-0690

[Summary] [PDF] [Pay per view] [Export citation]
11.

Online Supplementary Material

N. Medvedev (1), R. Palankar (1), K. Krauel (2), A. Greinacher (2), M. Delcea (1)

(1) ZIK HIKE-Zentrum für Innovationskompetenz „Humorale Immunreaktionen bei kardiovaskulären Erkrankungen“, Greifswald, Germany; (2) Institut für Immunologie und Transfusionsmedizin, Greifswald, Germany

Thromb Haemost 2014 111 5: 862-872

https://doi.org/10.1160/TH13-09-0752

[Summary] [PDF] [Pay per view] [Export citation]
12.

Online Supplementary Material

L. Wang (1, 2), N. N. Soe (1), M. Sowden (1), Y. Xu (1), K. Modjeski (1), P. Baskaran (3), Y. Kim (1), E. M. Smolock (1), C. N. Morrell (1), B. C. Berk (1)

(1) Aab Cardiovascular Research Institute and the Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA; (2) Department of Cardiology, Drum Tower Hospital, Nanjing University Medical School, Nanjing, China; (3) School of Pharmacy, College of Health Sciences, University of Wyoming, Laramie, Wyoming, USA

Thromb Haemost 2014 111 5: 873-882

https://doi.org/10.1160/TH13-09-0738

[Summary] [PDF] [Pay per view] [Export citation]
13.

Online Supplementary Material

R. F. Storey (1), J. Kotha (2), S. Smyth (3), D. J. Moliterno (3), T. L. Rorick (4), T. Moccetti (5), M. Valgimigli (6), J. P. Dery (7), J. H. Cornel (8), G. S. Thomas (9), K. Huber (10), R. A. Harrington (4), E. Hord (2), H. M. Judge (1), E. Chen (11), J. Strony (11), K. W. Mahaffey (4), P. Tricoci (4), R. C. Becker (4), L. K. Jennings (2, 12)

(1) Department of Cardiovascular Science, University of Sheffield, Sheffield, UK; (2) CirQuest Labs, LLC, Memphis, Tennessee, USA; (3) Lexington VA Medical Center and Gill Heart Institute, University of Kentucky, Lexington, Kentucky, USA; (4) Duke Clinical Research Institute, Cardiovascular Research, Duke University Medical Center, Durham, North Carolina, USA; (5) Cardiocentro Ticino, Lugano, Switzerland; (6) Azienda Ospedaliero-Universitaria Sant’Anna, Ferrara, Italy; (7) Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada; (8) Medical Center Alkmaar, Alkmaar, The Netherlands; (9) Mission Internal Medical Group, Mission Viejo, California, USA and University of California, Irvine, California, USA; (10) Wilhelminenhospital, Vienna, Austria; (11) Merck & Co., Inc., Whitehouse Station, New Jersey, USA; (12) University of Tennessee Health Science Center, Memphis, Tennessee, USA

Thromb Haemost 2014 111 5: 883-891

https://doi.org/10.1160/TH13-07-0624

[Summary] [PDF] [Pay per view] [Export citation]
14.

C.-Y. Kuo (1), H.-C. Wang (1), P.-H. Kung (1), C.-Y Lu (2), C.-Y. Liao (1), M.-T. Wu (3), C.-C. Wu (1)

(1) Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan; (2) Department of Biochemistry, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; (3) Department of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

Thromb Haemost 2014 111 5: 892-901

https://doi.org/10.1160/TH13-07-0629

[Summary] [PDF] [Pay per view] [Export citation]
15.
Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression
Results from micro-array profiling in a cohort of 60 patients

Online Supplementary Material

C. Stratz (1), T. Nührenberg (1), B. L. Fiebich (1, 2, 3), M. Amann (1), A. Kumar (2, 4), H. Binder (5, 6), I. Hoffmann (5), C. Valina (1), W. Hochholzer (1), D. Trenk (1), F.-J. Neumann (1)

(1) Universitäts-Herzzentrum Freiburg – Bad Krozingen, Abteilung für Kardiologie und Angiologie II, Bad Krozingen, Germany; (2) Department of Psychiatry and Psychotherapy, University Medical Centre Freiburg, Freiburg, Germany; (3) VivaCell Biotechnology GmbH, Denzlingen, Germany; (4) University of Freiburg, Faculty of Biology, Freiburg, Germany; (5) Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre Johannes Gutenberg University Mainz, Mainz, Germany; (6) Institute of Medical Biometry and Medical Informatics, University Medical Centre Freiburg, Freiburg, Germany

Thromb Haemost 2014 111 5: 902-911

https://doi.org/10.1160/TH13-06-0476

[Summary] [PDF] [Pay per view] [Export citation]
16.
Risk of bleeding and antibiotic use in patients receiving continuous phenprocoumon therapy
A case-control study nested in a large insurance- and population-based German cohort

S. Abbas (1), P. Ihle (1), S. Harder (2), I. Schubert (1)

(1) PMV Research Group at the Department of Child and Adolescent Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany; (2) Institute of Clinical Pharmacology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany

Thromb Haemost 2014 111 5: 912-922

https://doi.org/10.1160/TH13-09-0723

[Summary] [PDF] [Pay per view] [Export citation]
17.

S. P. Nisar (1), M. Lordkipanidzé (2), M. L. Jones (3), B. Dawood (2), S. Murden (3), M. R. Cunningham (1), A. D. Mumford (3), J. T. Wilde (4), S. P. Watson (2), S. J. Mundell (1), G. C. Lowe (2), on behalf of the UK GAPP study group

(1) School of Physiology and Pharmacology, Medical Sciences Building, University of Bristol, Bristol, UK; (2) Centre for Cardiovascular Sciences, Institute of Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK; (3) Bristol Heart Institute & School of Cellular and Molecular Medicine, University of Bristol, Bristol, Bristol, UK; (4) West Midlands Adult Haemophilia Comprehensive Care Centre, University Hospital Brimingham, Edgbaston, Birmingham, UK

Thromb Haemost 2014 111 5: 923-932

https://doi.org/10.1160/TH13-08-0672

[Summary] [PDF] [Pay per view] [Export citation]
18.
Patient outcomes using the European label for dabigatran
A post-hoc analysis from the RE-LY database

G. Y. H. Lip (1), A. Clemens (2), H. Noack (3), J. Ferreira (4), S. J. Connolly (5), S. Yusuf (5)

(1) University of Birmingham, Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK; (2) Medical Data Services, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany; (3) Global Clinical Development and Medical Affairs, Boehringer Ingelheim GmbH&Co.KG, Ingelheim am Rhein, Germany; (4) Cardiology Department, Hospital de Santa Cruz, Carnaxide, Portugal; (5) Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada

Thromb Haemost 2014 111 5: 933-942

https://doi.org/10.1160/TH13-09-0734

[Summary] [PDF] [Pay per view] [Export citation]
19.

Online Supplementary Material

D. Erlinge (1), S. James (2), S. Duvvuru (3), J. A. Jakubowski (3), H. Wagner (1), C. Varenhorst (2), U. S. Tantry (4), P. B. Brown (3), D. Small (3), B. A. Moser (3), S. S. Sundseth (5), J. R. Walker (6), K. J. Winters (3), P. A. Gurbel (4)

(1) Department of Cardiology, Lund University, Lund, Sweden; (2) Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Sweden; (3) Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; (4) Sinai Center for Thrombosis Research, Baltimore, MD, USA; (5) Cabernet Pharmaceuticals Durham, NC, USA; (6) Daiichi Sankyo Pharma Development, Edison, NJ, USA

Thromb Haemost 2014 111 5: 943-950

https://doi.org/10.1160/TH13-09-0767

[Summary] [PDF] [Pay per view] [Export citation]
20.

Online Supplementary Material

M. Li (1), D. Gallo (1), E. Csizmadia (1), L. E. Otterbein (1), B. Wegiel (1)

(1) Department of Surgery, Transplant Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA

Thromb Haemost 2014 111 5: 951-959

https://doi.org/10.1160/TH13-09-0748

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-26